AI
CRBU icon

Atom Investors’s Caribou Biosciences CRBU Stock Holding History

Atom Investors’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-160,661
Closed -$921K – 594
2023
Q4 		$921K Buy
160,661
+37,234
+30% +$184K 0.16% 197
2023
Q3 		$590K Buy
+123,427
New +$766K 0.13% 202
2022
Q3 		– Sell
-14,844
Closed -$81K – 306
2022
Q2 		$81K Buy
+14,844
New +$113K 0.04% 223
2022
Q1 		– Sell
-16,323
Closed -$246K – 228
2021
Q4 		$246K Buy
+16,323
New +$317K 0.04% 220

Other funds holding CRBU

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Atom Investors's CRBU Position: Q1 2024 in Review

Atom Investors sold out of Caribou Biosciences (CRBU) in Q1 2024, closing a stake of 160,661 shares — an estimated $921K sold.

Atom Investors first reported a position in CRBU in Q4 2021 and held it in 4 quarters. The position peaked at $921K in Q4 2023. 151 funds tracked by Wall St. Rank hold CRBU as of Q1 2024.

  • Atom Investors reported no remaining Caribou Biosciences position as of Q1 2024 after selling out during the quarter.
  • Atom Investors sold 160,661 Caribou Biosciences shares in Q1 2024, an estimated $921K.
  • Atom Investors first reported a position in Caribou Biosciences in Q4 2021 and held it in 4 quarters.
  • Atom Investors's Caribou Biosciences position peaked at $921K in Q4 2023.
  • 151 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2024.

Based on Atom Investors's 13F filing for Q1 2024, filed 15 May 2024.